文献速递鼻科

按需鼻内皮质类固醇喷雾治疗过敏性鼻炎:系统综述与荟萃分析

As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis.
PubMed 文献 · Rhinology · 2022-01-01

本系统综述与荟萃分析纳入8项随机对照试验共882例过敏性鼻炎患者,评估按需鼻内皮质类固醇喷雾(INCS)的疗效。结果显示规律使用INCS在鼻部总症状评分和疾病特异性生活质量上优于按需使用,但按需INCS在鼻部总症状评分上优于按需抗组胺药和安慰剂。三组比较中不良事件风险均无差异。

要点

  • 规律使用INCS在鼻部总症状评分和疾病特异性生活质量上优于按需INCS,效应量小。
  • 按需INCS在鼻部总症状评分上优于按需抗组胺药和安慰剂,效应量中等。
  • 按需INCS与规律INCS在眼部症状、无症状天数、鼻痒和流涕评分上无差异。

核心结论

  • 规律使用INCS改善鼻部总症状评分和疾病特异性生活质量优于按需INCS。
  • 按需INCS改善鼻部总症状评分优于按需抗组胺药和安慰剂。
  • 按需INCS的效应更接近规律INCS而非安慰剂或按需抗组胺药。

研究设计与样本

  • 系统检索随机对照试验,比较按需INCS与规律INCS、按需抗组胺药或安慰剂的效果。
  • 共纳入8项研究,882例参与者。
  • 主要结局为鼻部总症状评分(TNSS)和疾病特异性生活质量(DSQoL)。

主要发现

  • 规律使用INCS在TNSS、DSQoL、鼻吸气峰流量、打喷嚏和鼻塞评分上优于按需INCS,效应量小。
  • 规律与按需INCS在眼部症状、无症状天数、鼻痒和流涕评分上无差异。
  • 按需INCS优于按需抗组胺药和安慰剂,效应量中等。
  • 三种比较中,组间不良事件风险均无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As-needed intranasal corticosteroid spray (INCS) is commonly used by patients with allergic rhinitis (AR) who have suboptimal symptom control. This systematic review aimed to assess the effectiveness of as-needed INCS for treating AR. METHODOLOGY: Systematic searches for randomized controlled trials studying the effects of as-needed INCS compared to regular INCS, as-needed antihistamine, or placebo were performed. Primary outcomes were total nasal symptom score (TNSS) and disease-specific quality of life (DSQoL). RESULTS: Eight studies (882 participants) met the criteria. Regular use of INCS showed greater improvements than as-needed INCS in TNSS, DSQoL, nasal peak inspiratory flow, sneezing, and nasal congestion scores with small effect sizes. There were no differences between regular and as-needed INCS usage for ocular symptoms, symptom-free days, nasal itching, and rhinorrhea scores. As-needed INCS was superior to as-needed antihistamine and placebo with medium effect sizes. There were no differences in risk of adverse events between the groups in all three comparisons. CONCLUSIONS: Regular use of INCS improved total nasal symptoms score and DSQoL better than as-needed INCS. However, as-needed INCS improved TNSS better than as-needed antihistamine and placebo. The effects of as-needed INCS were closer to regular INCS usage than to placebo or as-needed AH usage.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Hoang MP, Chitsuthipakorn W, Seresirikachorn K, et al. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis. Rhinology. 2022. PMID: 35379997. doi:10.4193/Rhin21.355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。